Dechra Pharmaceuticals buys two European pharma companies

| By | Pharmaceutical Deal, Veterinary drugs

Dechra Pharmaceuticals, a UK veterinary company, announced the acquisition of two European pharmaceutical business as well as a share placing to part-fund the purchases.

Dechra is to buy Dutch animal pharmaceuticals firm AST Farma and European animal-focused company Le Vet, for a combined price of EUR340.0 million. The total consideration will be paid 75% in cash and 25% in new Dechra shares.

The two firms have worked together, Dechra said, to develop a strong product portfolio and a network of marketing partners across Europe. Together, they hold around 90 product registrations.

“The acquisition is a rare opportunity to strengthen our EU segment in all the major European countries in which we operate. AST Farma and Le Vet have been a primary target for a number of years so we are delighted to have reached this agreement,” commented Ian Page, Dechra’s CEO.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.